Decoding depression: sleep rhythms as biomarkers?
NCT ID NCT05866991
First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time
Summary
This study builds a large French cohort of 1,000 people experiencing a major depressive episode to examine their sleep and circadian rhythms. Researchers will use sleep recordings (polysomnography) and psychiatric evaluations to identify distinct patient subgroups and potential biomarkers. The goal is to better understand the biology of depression and pave the way for more personalized care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- This could help identify biological markers of depression, leading to more personalized diagnosis and treatment approaches.
- What could go wrong
- As an observational study, it cannot prove cause and effect. The findings may not translate into immediate clinical tools or benefit all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE EPISODE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Bichat Claude Bernard
RECRUITINGParis, Paris, 75018, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain wave clues: could inflammation markers forecast ECT outcomes?
- Brain wave patterns and inflammation: a clue to ECT's effectiveness in older adults?
- Magnetic brain pulses aim to quiet suicidal urges
- Could a flickering light headset lift depression?
- Depression genes under the microscope: new study aims to uncover clues
- Brain zaps at home may boost sleep and fight depression